# 3B BlackBio Dx Ltd (3BBLACKBIO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1236.2
Day Change: +2.5%
52W High: ₹1424.7
52W Low: ₹1166.5
Market Cap: ₹1,178 Cr

## Valuation
P/E: 0
P/B: 3.86
EPS: ₹0
Book Value: ₹355.75
Dividend Yield: 0%

## Returns
1Y Return: -21.97%

## Profitability
ROE: 533.33%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 98.3%
Profit Growth: 66.3%
EBITDA Margin: 43.53%
Operating Margin: 42.39%

## About
3B BlackBio Dx Ltd is a Biotechnology company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Biotechnology
Sub Industry: Unknown

## Business Model
Overview: 3B BlackBio Dx Ltd makes money through Technology services, Digital transformation projects, Maintenance and managed services in Biotechnology. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Technology services
- Digital transformation projects
- Maintenance and managed services
Operating Model:
- Wins client contracts, deploys skilled delivery teams, and earns project or recurring service revenue.
- Utilisation, billing rates, attrition, and currency movements are key operating levers.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Securities Of The Companies Permitted To Trade And Admitted To Dealings On The National Stock Exchange
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-25T20:00:13.927Z
Price History Updated: 2026-05-25T05:24:14.653Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:24:14.653Z
Quant Updated: 2026-05-25T05:24:14.653Z
Sentiment Updated: 2026-05-25T05:24:14.653Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹22 Cr
Operating Profit: ₹1 Cr (OPM 6%)
Net Profit: ₹0 Cr
Tax: ₹0 Cr

## Annual P&L History
Mar 2015: Rev ₹22Cr | PAT ₹0Cr | OPM 6%
Mar 2016: Rev ₹19Cr | PAT ₹0Cr | OPM 7%
Mar 2017: Rev ₹17Cr | PAT ₹0Cr | OPM 9%

## Balance Sheet (Mar 2015)
Total Assets: ₹24 Cr
Total Liabilities: ₹24 Cr
Borrowings: ₹7 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Dhirendra Kuber Dubey, Chairman & MD
- Nikhil Kuber Dubey, CFO & Whole-Time Director
- Navneet  Kaur, Compliance Officer & Company Secretary

---
Source: rupiya.io/stocks/3bblackbio
Disclaimer: For research and education only. Not investment advice.